Aktieägarna i LUXBRIGHT AB, org. nr 556910-9837, har idag kallats till extra bolagsstämma tisdagen den 24 mars 2020 klockan 13:00 i konferensrummet på plan 5 i Bolagets lokaler på Arvid Wallgrens Backe 20 i Göteborg. Aktieägare som önskar delta i stämman ska dels vara införd i aktieboken tisdagen den 24 mars 2020, dels senast måndagen den 23 mars anmäla sitt deltagande vid stämman genom e-post till [email protected] eller per post till bolagets adress.
Aktieägarna i Luxbright AB, 556910-9837, kallas till årsstämma den 10 juni 2019 kl. 17.00 i konferensrummet på plan 5 vid bolagets lokaler på Arvid Wallgrens Backe 20 i Göteborg.
RÄTT ATT DELTA OCH ANMÄLAN
Den som önskar delta på stämman ska vara införd i den av bolaget förda aktieboken per dagen för stämman. Aktieägare uppmanas att anmäla närvaro (och eventuella biträden) till bolaget senast den 6 juni 2019 till bolagets postadress eller via e-post [email protected] Vid anmälan bör uppges namn, person-/organisationsnummer, adress, telefonnummer, registrerat aktieinnehav samt i förekommande fall uppgift om ombud och biträden.
Shareholders of Luxbright AB, 556910-9837, are invited to attend the Annual General Meeting on June 10th, 2019 at 17:00 at the Biotech Center conference room on level 5 located at the company's premises at Arvid Wallgrens Backe 20 in Gothenburg.
RIGHT TO PARTICIPATE AND REGISTRATION
Shareholders wishing to participate in the Annual General Meeting should be listed in the share register kept by the company as per the day of the meeting. Shareholders are encouraged to notify their presence (and any assistants) to the company by June 6, 2019, to the company's postal address or via e-mail [email protected] The notification should include the name, personal/organizational number, address, telephone number, registered shareholding and, if applicable, information on representatives and assistants should be stated.
GOTHENBURG, SWEDEN–(12 November 2018) Luxbright AB, a Swedish manufacturer of innovative microfocus X-ray tubes, is pleased to announce that its X-ray Device patent application has now been granted by the European Patent Office, Russian Federation, Mexico, and South Africa. The approvals mark a significant milestone for the company and validate the uniqueness of its X-ray innovation.
Dating back to the 1700’s, the postal service in various countries has been used to transport packages intended to injure or even kill the recipient.
A more recent and infamous example is the USA terrorist “Unabomber,” also known as Ted Kaczynski, who killed and injured several people via mail bombs from 1978-1995. If you have not seen the Netflix Show “Manhunt Unabomber,” it may be time to do some binge-watching. Another example you may be more familiar with is the USA’s anthrax scare during 2001. A slew of anthrax-laced packages were sent that year killing five people and injuring seventeen. Preventative measures were quickly taken to help reduce the risk of further related incidents.
Nonetheless, postal threats remain a global issue.
We hear a lot of buzz regarding how artificial intelligence (AI) will affect our future, but we don’t hear much in everyday conversation on how they will impact the X-ray space. AI technology is currently being used heavily in radiology to improve diagnosis.
A vast majority of the western world has had an X-ray taken at one point or another. X-rays help provide vital information to doctors on how to treat their patients. That said, X-rays use ionizing radiation which can increase the risk of cancer even in low doses.